Future studies should employ CRISPR-based gene editing in keratinocyte or macrophage models to dissect XDH-specific roles, coupled with preclinical trials in rosacea animal models (e.g., LL37-induced mice) to assess translational potential. This evidence concerns the gene XDH and rosacea.